Literature DB >> 6368493

Lymphoreticular tumors of the orbit.

P J Fitzpatrick, S Macko.   

Abstract

Lymphoreticular tumors in the orbit are uncommon. Only 42 patients were identified from over 2000 patients with tumors of lymphoid tissue seen between 1958 and 1979. The patients were divided into 3 groups: primary malignant, secondary malignant, and benign lymphoma. In the primary malignant lymphoma groups, there were 24 patients with a median age of 64 (40 to 87) years and a 2.4:1 female to male ratio: 2 cases were bilateral. In 19 (79%) patients with the lymphoma limited to one orbit the tumor was controlled in every case with doses from 25 to 45 Gy. There were no serious complications. Subsequently lymphoma developed at other sites in 7 (37%) patients. The 5 and 10 year cause specific actuarial survival rates were 70 and 62%. In the 8 patients with secondary malignant lymphoma, the orbital disease was controlled by irradiation, although all patients required further treatment and died of their disease. Radiotherapy controlled all 7 patients with benign lymphoma without any complications.

Entities:  

Mesh:

Year:  1984        PMID: 6368493     DOI: 10.1016/0360-3016(84)90051-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

Review 1.  Orbital lymphoproliferative disorders.

Authors:  A Garner
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

2.  Intensity-modulated radiation therapy for orbital lymphoma.

Authors:  Sharad Goyal; Alan Cohler; Jayne Camporeale; Venkat Narra; Ning J Yue
Journal:  Radiat Med       Date:  2009-01-08

3.  Radiotherapy of indolent orbital lymphomas : Two radiation concepts.

Authors:  Laila König; Robert Stade; Juliane Rieber; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2016-05-09       Impact factor: 3.621

4.  Non-autoimmune hyperthyroidism associated with isolated bilateral ocular lymphoma mimicking Graves' disease with ophthalmopathy: a cause of misdiagnosis.

Authors:  L Bartalena; S Brogioni; R Valeriano; M Nardi; F Cartei; F Bogazzi; E Martino
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

5.  Paediatric orbital lymphoma; a case series and review of the literature.

Authors:  Shay Keren; Matthew Lapira; Ewan McCallum; Zuzana Sipkova; Amrana Qureshi; Shaun Wilson; Jonathan H Norris; Goran D Hildebrand
Journal:  Eye (Lond)       Date:  2022-09-28       Impact factor: 4.456

6.  Primary orbital non-Hodgkin's lymphoma.

Authors:  Sonal Amit; Neetu Purwar; Asha Agarwal; Shrivastava Kanchan
Journal:  BMJ Case Rep       Date:  2012-10-19

7.  Dosimetric advantage of volumetric modulated arc therapy in the treatment of intraocular cancer.

Authors:  Zhenxiang Deng; Lanxiao Shen; Xiaomin Zheng; Yongqiang Zhou; Jinling Yi; Ce Han; Congying Xie; Xiance Jin
Journal:  Radiat Oncol       Date:  2017-05-10       Impact factor: 3.481

8.  Paediatric ocular adnexal lymphoma: a population-based analysis.

Authors:  Giannis A Moustafa; Allan K Topham; Mary E Aronow; Demetrios G Vavvas
Journal:  BMJ Open Ophthalmol       Date:  2020-06-21

Review 9.  Orbital lymphoma: role of radiation.

Authors:  B S Yadav; S C Sharma
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

10.  Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas.

Authors:  Wei-Li Ma; Ming Yao; Shu-Lang Liao; Jih-Luh Tang; Yao-Ching Wang; Sung-Hsin Kuo; Ann-Lii Cheng
Journal:  Oncotarget       Date:  2017-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.